Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$441K Buy
1,254
+145
+13% +$51.7K 0.24% 51
2025
Q4
$363K Buy
1,109
+15
+1% +$4.76K 0.2% 56
2025
Q3
$309K Sell
1,094
-20
-2% -$5.8K 0.17% 61
2025
Q2
$311K Buy
1,114
+116
+12% +$32.9K 0.18% 59
2025
Q1
$311K Sell
998
-418
-30% -$123K 0.17% 55
2024
Q4
$369K Buy
1,416
+63
+5% +$18.7K 0.19% 48
2024
Q3
$436K Buy
1,353
+233
+21% +$76.2K 0.25% 39
2024
Q2
$350K Buy
1,120
+329
+42% +$96.7K 0.22% 43
2024
Q1
$225K Buy
+791
New +$231K 0.15% 55
2023
Q1
Sell
-834
Closed -$219K 51
2022
Q4
$219K Buy
+834
New +$224K 0.19% 49

Other funds holding AMGN

Tower Wealth Partners's AMGN Position: Q1 2026 in Review

Tower Wealth Partners increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $51.7K and bringing the position to 1,254 shares worth $441K. The position accounts for 0.24% of the portfolio, ranked #51.

Tower Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tower Wealth Partners held 1,254 shares of Amgen worth $441K as of Q1 2026.
  • Tower Wealth Partners bought 145 Amgen shares in Q1 2026, an estimated $51.7K.
  • Amgen made up 0.24% of Tower Wealth Partners's portfolio in Q1 2026, its #51 holding.
  • Tower Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tower Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.